Skip to content

Use Of Prophylactic Tranexamic Acid For Reducing Blood Loss At Caesarean Section In Women At High Risk Of Postpartum Haemorrhage at University of Nigeria Teaching Hospital Ituku-ozalla Enugu: A Double-Blind Placebo Randomised Controlled Study

Use Of Prophylactic Tranexamic Acid For Reducing Blood Loss At Caesarean Section In Women At High Risk Of Postpartum Haemorrhage at University of Nigeria Teaching Hospital Ituku-ozalla Enugu: A Double-Blind Placebo Randomised Controlled Study

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
PACTR
Registry ID
PACTR202603864365244
Enrollment
116
Registered
2026-03-30
Start date
2024-09-01
Completion date
Unknown
Last updated
2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

high-risk pregnant women including placenta praevia, placental abruptio, and uterine rupture

Interventions

Tranexamic acid
water for injection

Sponsors

Ezugwu Ifeanyi Anthony
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: Patients who have given consent for caesarean delivery. The pregnant women must be at least 18 years old. The participant must be a high-risk pregnancy. Term pregnancies (37 weeks to 41 weeks + 6days).

Exclusion criteria

Exclusion criteria: Patient who refused to give consent Uterine rupture Intra-uterine fetal death History of bleeding disorders Known allergy to tranexamic acid History of thrombo-embolism Low risk pregnancies

Design outcomes

Primary

MeasureTime frame
Primary outcome measures will be the mean intra-operative blood loss during caesarean delivery

Secondary

MeasureTime frame
Secondary outcome measures will include use of additional uterotonics, need for blood transfusion, need for surgical intervention, postpartum maternal anaemia and adverse effects (nausea, vomiting, thrombo-embolism and coagulopathy, seizures, headaches, back ache, anaphylactic reaction and impaired vision), perinatal outcomes such as first and fifth minute appearance, pulse, grimace, activity and respiratory movement (APGAR SCORES) and neonatal intensive care unit admission.

Countries

Nigeria

Contacts

Public ContactIjeoma Ezeome

Head of Department of Obstetrics and Gynaecology University of Nigeria Teaching Hospital

ezeomeij@gmail.com08058124721

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Sep 19, 2026